Insiders
psychoactive | The New Statesman| 1 February
The so-called psychedelic elite
Interventions
psychoactive | The Lancet| 1 February
Psychedelics for health
Addiction
psychoactive | The Conversation| 3 February
Illicit drugs as a global threat
Psymposia
psychoactive | The New York Times | 5 February
The cog in Lykos’ wheels
Portugal
psychoactive | Truth Dig | 6 February
A different approach to the war on drugs
Marijuana
psychoactive | The New York Times | 6 February
On Cannabis Use Disorder
History
culture | Aeon | 7 February
For the Aztecs, there was no single truth about the past
High-end spirituality
psychoactive | Ecstatic Integration | 8 February
On the nexus of wealth, hedonism and psychedelic/New Age spirituality
LSD
psychoactive | Psychiatric Times | 10 February
MindMed’s phase 3 trials for Generalized Anxiety Disorder underway
Opioids
psychoactive | The Globe and Mail | 11 February
Harsher punishments of Fentanyl offenders leads to more misery
UK
psychoactive | Parliamentary Office of Science & Technology | 12 February
Psychedelic-assisted therapy for mental health: policy considerations
Israel & Palestine
culture | The Conversation | 14 February
What the Bible says about the promised land
Addiction II
psychoactive | The Conversation | 14 February
Are antidpressants really as hard to kick as heroin?
Religion
psychoactive | Double Blind | 16 February
The first Black-owned psychedelic church has opened its doors in Oakland
Dying
psychoactive | Popular Mechanics | 18 February
DMT controls our consciousness at the moment of death
Psychedelics
culture | DoubleBlind | 23 February
A new Jewish counterculture
Longevity
science | The New York Times | 25 February
Why women live longer than men
Fashionable
psychoactive | Reality Sandwich | 26 February
Is ketamine the new cocaine?
Psycedelic-assisted therapy
psychoactive | Science Direct | February
Enhancing spirituality and mystical experiences in patients with life-threatening illnesses: A systematic review